Sun Pharmaceutical Industries Ltd. benchmarking: Performance to industry peers

Financial

	Sun Pharma Inds.	Torrent Pharma	Dr. Reddy's Lab
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	665.0 .	172.0 .	371.0 .
Number of ANDA's Approved By USFDA	548.0 .	132.0 .	300.0 .
Domestic Sales Growth - YoY	14.6 %	11.6 %	11.3 %
US DMF Filings	532.0 .	n/a	n/a
US DMF Approval	402.0 .	n/a	n/a
R&D as a % of Total Sales	5.4 %	5.0 %	7.0 %
Financials
5 yr Average ROE	11.67 %	20.79 %	15.68 %
5yr average Equity Multiplier	1.33	2.16	1.41
5yr Average Asset Turnover Ratio	0.57	0.69	0.74
5yr Avg Net Profit Margin	15.4 %	13.95 %	15.18 %
Price to Book	5.69	17.55	2.8
P/E	40.58	65.25	25.26
5yr Avg Cash Conversion Cycle	-46.88 Days	-186.79 Days	74.48 Days
Inventory Days	65.22 Days	54.98 Days	76.14 Days
Days Receivable	84.33 Days	40.18 Days	95.44 Days
Days Payable	175.41 Days	298.32 Days	102.6 Days
5yr Average Interest Coverage Ratio	44.12	7.38	35.66
5yr Avg ROCE	18.0 %	25.78 %	21.82 %
5yr Avg Operating Profit Margin	26.44 %	30.49 %	23.61 %
5 yr average Debt to Equity	0.06	0.66	0.12
5yr CAGR Net Profit	30.35 %	8.83 %	23.71 %
5yr Average Return on Assets	8.92 %	9.73 %	11.24 %
Shareholdings
Promoter Holding	54.48 %	68.31 %	26.63 %
Share Pledged by Promoters	1.42 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-2.94 %	-0.07 %
Change in Mutual Fund Holding (3 Yrs)	-0.95 %	-1.92 %	3.32 %

Business

	Sun Pharma Inds.	Torrent Pharma	Dr. Reddy's Lab
Product Wise Break-Up	Product Wise Break-Up India Branded Generics 33.0 US Formulations 30.0 Emerging Market 20.0 Western Europe & Other Markets 14.0 Active Pharmaceutical Ingredient (API) 3.0 Domestic formulations 0 Contract Manf. 0 Brazil/Latam 0 Germany/Europe 0 Proprietary Products 0 Global Generics 0 0	Product Wise Break-Up Contract Manufacturing 6.15 0 Emerging Market 0 Brazil 8.98 Domestic Formulations 42.15 Germany 13.15 Global Generics 0 Western Europe & Other Markets 0 US Formulations 20.71 Proprietary Products 0 India Branded Generics 0 Active Pharmaceutical Ingredient (API) 0 Others 8.86	Product Wise Break-Up Contract Manf. 0 Pharmaceutical 10.62 Emerging Market 0 Brazil/Latam 0 Domestic formulations 0 Germany/Europe 0 Formulations 89.21 Western Europe & Other Markets 0 US Formulations 0 Proprietary 0.17 India Branded Generics 0 Active Pharmaceutical Ingredient (API) 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 19.0 Cardiac Science 17.0 Gastro Intestinal 14.0 Anti - Diabetes 9.0 Pain Management 7.0 Anti-Infective 6.0 Respiratory Systems 5.0 Vitamins / Minerals / Nutrients 5.0 Gynecology 4.0 Dermatology 4.0 Ophthalmology 3.0 Urology 3.0 Others 4.0	-	-
Location Wise Break-Up	Location Wise Break-Up India 33.39 USA 32.68 Emerging Market 19.13 Rest of the World 14.8 Germany 0 Brazil 0 Russia 0	Location Wise Break-Up India 54.44 Rest of the World 0 Emerging Market 0 Russia 0 Germany 9.2 USA 9.72 Brazil 11.23 Others 15.41	Location Wise Break-Up India 17.36 Rest of the World 0 Emerging Market 0 Russia 7.99 Germany 0 USA 48.56 Brazil 0 Others 26.09

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

Financial

Business

SIGN UP FOR FREE